14-day Premium Trial Subscription Try For FreeTry Free
Date Action Amount Person Type
Jun 21, 2023 Buy 40 000 Barbier Ann Stock Option (right to buy)
Jun 21, 2023 Buy 45 000 Geraghty James A Stock Option (right to buy)
Jun 21, 2023 Buy 40 000 Kiener Peter A Stock Option (right to buy)
Jun 21, 2023 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 21, 2023 Buy 40 000 Richman Michael Stock Option (right to buy)
Jun 21, 2023 Buy 40 000 Said Maya R. Stock Option (right to buy)
Jun 21, 2023 Buy 40 000 Sherman Matthew L Stock Option (right to buy)
May 25, 2023 Buy 10 000 Kiritsy Christopher P Common Stock
May 11, 2023 Buy 0 Bvf Partners L P/il Common Stock, $0.001 par value
May 11, 2023 Buy 0 Bvf Partners L P/il Common Stock, $0.001 par value
May 11, 2023 Buy 0 Bvf Partners L P/il Common Stock, $0.001 par value
May 11, 2023 Buy 85 000 Bvf Partners L P/il Series A Convertible Preferred Stock, $0.001 par value
May 11, 2023 Buy 284 000 Bvf Partners L P/il Series B Convertible Preferred Stock, $0.001 par value
May 11, 2023 Buy 265 000 Bvf Partners L P/il Series C Convertible Preferred Stock, $0.001 par value
May 11, 2023 Buy 163 000 Bvf Partners L P/il Series D Convertible Preferred Stock, $0.001 par value
May 11, 2023 Buy 161 000 Bvf Partners L P/il Series E Convertible Preferred Stock, $0.001 par value
May 11, 2023 Buy 265 000 Bvf Partners L P/il Tranche C Warrants
Feb 24, 2023 Buy 249 080 Bures Thomas Stock Option (right to buy)
Feb 24, 2023 Buy 249 080 Kaufmann Hitto Stock Option (Right to buy)
Feb 24, 2023 Buy 249 080 Mousa Ahmed Stock Option (Right to buy)
Feb 24, 2023 Buy 249 080 Olwill Shane Stock Option (Right to buy)
Feb 24, 2023 Buy 634 021 Yoder Stephen S. Stock Option (Right to buy)
Jun 22, 2022 Buy 40 000 Barbier Ann Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Barbier Ann Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Said Maya R. Stock Option (right to buy)
Jun 22, 2022 Buy 45 000 Geraghty James A Stock Option (right to buy)
Jun 22, 2022 Buy 45 000 Geraghty James A Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Kiener Peter A Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Kiener Peter A Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Richman Michael Stock Option (right to buy)
Jun 22, 2022 Buy 40 000 Sherman Matthew L Stock Option (right to buy)
May 13, 2022 Buy 6 000 Demuth Tim Common Stock
Feb 22, 2022 Buy 100 000 Demuth Tim Stock Option (Right to buy)
Feb 22, 2022 Buy 215 819 Mousa Ahmed Stock Option (Right to buy)
Feb 22, 2022 Buy 215 819 Olwill Shane Stock Option (Right to buy)
Feb 22, 2022 Buy 215 819 Bures Thomas Stock Options (Right to buy)
Feb 22, 2022 Buy 215 819 Kaufmann Hitto Stock Option (Right to buy)
Feb 22, 2022 Buy 625 874 Yoder Stephen S. Stock Option (Right to buy)
Oct 06, 2021 Buy 65 000 Mousa Ahmed Stock Option (right to buy)
Oct 06, 2021 Buy 125 000 Mousa Ahmed Stock Option (right to buy)
Oct 06, 2021 Buy 45 000 Mousa Ahmed Stock Option (right to buy)
Oct 06, 2021 Buy 65 000 Mousa Ahmed Stock Option (right to buy)
Oct 06, 2021 Buy 95 000 Mousa Ahmed Stock Option (right to buy)
Oct 06, 2021 Buy 150 000 Mousa Ahmed Stock Option (right to buy)
Aug 30, 2021 Sell 38 400 Olwill Shane Stock Option (right to buy)
Aug 30, 2021 Buy 38 400 Olwill Shane Common Stock
Aug 30, 2021 Sell 9 200 Olwill Shane Common Stock
Aug 30, 2021 Sell 29 200 Olwill Shane Common Stock
Aug 01, 2021 Buy 360 000 Demuth Tim Stock Option (right to buy)
Aug 01, 2021 Buy 0 Demuth Tim
Aug 01, 2021 Buy 0 Olwill Shane Common Stock
Aug 01, 2021 Buy 150 000 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 145 000 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 100 000 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 56 250 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 90 000 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 82 000 Olwill Shane Stock Option (right to buy)
Aug 01, 2021 Buy 90 000 Olwill Shane Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Sherman Matthew L Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Said Maya R. Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Richman Michael Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Kiener Peter A Stock Option (right to buy)
Jun 25, 2021 Buy 45 000 Geraghty James A Stock Option (right to buy)
Jun 25, 2021 Buy 40 000 Barbier Ann Stock Option (right to buy)
Mar 04, 2021 Buy 150 000 Bures Thomas Stock Options (Right to buy)
Mar 04, 2021 Buy 220 000 Kaufmann Hitto Stock Options (Right to buy)
Mar 04, 2021 Buy 530 000 Yoder Stephen S. Stock Options (Right to buy)
Jul 21, 2020 Sell 1 900 000 Aquilo Capital Management, Llc Common Stock, $0.001 par value
Jun 25, 2020 Buy 40 000 Said Maya R. Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Said Maya R. Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Sherman Matthew L Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Richman Michael Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Kiritsy Christopher P Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Kiener Peter A Stock Options (Right to buy)
Jun 23, 2020 Buy 45 000 Geraghty James A Stock Option (right to buy)
Jun 23, 2020 Buy 40 000 Barbier Ann Stock Options (Right to buy)
Mar 12, 2020 Buy 0 Aquilo Capital Management, Llc Common Stock, $0.001 par value
Feb 27, 2020 Buy 80 000 Bures Thomas Stock Option (Right to Buy)
Feb 27, 2020 Buy 45 000 Kaufmann Hitto Stock Option (Right to Buy)
Feb 27, 2020 Buy 420 000 Yoder Stephen S. Stock Option (Right to Buy)
Jan 25, 2020 Buy 20 000 Sherman Matthew L Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Said Maya R. Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Kiener Peter A Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Barbier Ann Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Kiritsy Christopher P Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Bizzari Jean-pierre Stock Option (right to buy)
Jan 25, 2020 Buy 20 000 Richman Michael Stock Option (right to buy)
Jan 25, 2020 Buy 5 431 Richman Michael Stock Option (right to buy)
Jan 25, 2020 Buy 22 500 Geraghty James A Stock Option (right to buy)
Nov 04, 2019 Buy 1 126 761 Aquilo Capital Management, Llc Warrants
Oct 25, 2019 Buy 5 165 Richman Michael Stock Options (right to buy)
Sep 06, 2019 Sell 23 152 Bvf Partners L P/il Common Stock, $0.001 par value
Sep 06, 2019 Sell 25 720 Bvf Partners L P/il Common Stock, $0.001 par value
Sep 06, 2019 Sell 1 128 Bvf Partners L P/il Common Stock, $0.001 par value
Sep 06, 2019 Buy 0 Bvf Partners L P/il Common Stock, $0.001 par value
Sep 06, 2019 Buy 0 Bvf Partners L P/il Common Stock, $0.001 par value
INSIDER POWER
57.489
Last 100 transactions
Buy: 10 244 998 | Sell: 2 026 800 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 57.489.

In total, the insiders bought 10 244 998 and sold 2 026 800 PIRS shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Pieris Pharmaceuticals

Pieris Pharmaceuticals Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin-based drug candidate includes PRS-060/AZD1402, a drug candidate ... PIRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT